Underresearched and often dismissed, migraines have made their sufferers a resourceful bunch. But a promising new drug might finally offer relief.
To be clear: A migraine is not a headache, and people with migraines don’t like their condition to be called one. It’s not that headaches aren’t a part of a migraine: They are. But a headache is a single symptom of a multifaceted neurological disease— one that includes loss of vision, nausea, and sensitivity to light, sound, and smell. And those are just the common side effects. Some sufferers find themselves yawning compulsively, slurring their speech, and losing sensation on one side of their bodies. Some migraineurs (yes, that is the technically accurate moniker for migraine sufferers) start seeing big things as small—a side effect dubbed “Alice in Wonderland syndrome” by doctors.
Nonetheless, for as long as they have existed, migraines have been trivialized as headaches, or dismissed altogether. Which is clear when you look at the treatments available: Almost every drug used between 1550 B.C. and today has been a repurposed one. Poultices of opium and honey, Botox, antidepressants—drugs whose efficacy was not intended but stumbled upon. Triptan, a class of vessel constrictors created to abort (not prevent) attacks at their onset, was released in 1991 and has been the only class of drug created specifically for migraines—that is, until now. On May 17, a preventative drug called Aimovig, 30 years in the making, gained FDA approval; it’s a monthly shot that modulates patients’ levels of CGRP, a neurotransmitter whose levels rise during migraine attacks. This means that it could be in the hands (or arms— it’s injectable) of migraineurs within the month.
This story is from the May 28, 2018 edition of New York magazine.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 28, 2018 edition of New York magazine.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Unmasking Diddy
The rap mogul shook off decades of rumored bad behavior with wholesome PR revamps. Now the allegations against him are his legacy.
Staging Sufjan
How playwright Jackie Sibblies Drury turned a classic indie-rock album into a Justin Peck-choreographed dance piece that's now Broadway bound.
Justin Kuritzkes Serves an Ace
With his first movie script for the erotic tennis drama Challengers, he has gone from struggling playwright to in-demand screenwriter.
To Brooklyn, by Way of Paris and Rome
A whirlwind week with Dior creative director Maria Grazia Chiuri as she stages the brand's first New York runway show in a decade.
A Burlesque Family at Home
Showbiz couple Angie Pontani and Brian Newman’s high-spirited Marine Park house.
A Bistro With Shish Barak
Huda impressively balances its many influences.
THE 'DEBATE ME BRO
Mehdi Hasan's aggressive interviewing style landed him a Sunday show on MSNBC. Until he started talking about Palestine.
THE MAN WHO GOSSIPED TOO MUCH
For almost two decades, JOHN NELSON anonymously published blind items skewering the Hollywood elite on the blog CRAZY DAYS AND NIGHTS. Then his identity was revealed in the midst of a messy affair.
TODD BLANCHE IS A SURPRISINGLY COMPETENT LAWYER. AND HE'S ON TRACK TO KEEP HIS CLIENT OUT OF JAIL UNTIL THE ELECTION. IN DEFENSE OF TRUMP
TODD BLANCHE WAS looking for his man. Or it could be a woman, but probably not.
Self: Emma Alpern
In Outer Space Why do so many women believe their bodies are controlled by the moon?